We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

22 hedge funds and large institutions have $38.1K invested in CERo Therapeutics Warrants in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,058.8% more ownership

Funds ownership: 34.91% → 3,093.71% (+3,059%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

4% less funds holding

Funds holding: 23 → 22 (-1)

49% less capital invested

Capital invested by funds: $74.5K → $38.1K (-$36.4K)

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
1
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$2K

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$4.77K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.75K
3
VF
Virtu Financial
New York
+$11

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$10.5K
2
PA
Parallel Advisors
California
-$401
3
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$5
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Clear Street
New York
$6.14K +$4.77K +267,829 +138%
Toronto Dominion Bank
2
Toronto Dominion Bank
Ontario, Canada
$5.33K -$5 -300 -0.1%
MI
3
MMCAP International
Cayman Islands
$4.99K – – –
SCM
4
Saba Capital Management
New York
$4.26K – – –
LA
5
Linden Advisors
New York
$3.6K – – –
BOCH
6
Blue Owl Capital Holdings
New York
$2.99K – – –
QGA
7
Q Global Advisors
Texas
$2K – – –
CCM
8
Context Capital Management
California
$1.62K – – –
NAM
9
Nexpoint Asset Management
Texas
$1.45K – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$1.31K +$1.75K +98,468 New
PMAM
11
Picton Mahoney Asset Management
Ontario, Canada
$1K – – –
WCMNY
12
Westchester Capital Management (New York)
New York
$997 – – –
TCM
13
Tenor Capital Management
New York
$665 – – –
WAM
14
Wolverine Asset Management
Illinois
$449 – – –
PA
15
Parallel Advisors
California
$366 -$401 -22,500 -45%
WA
16
Whitebox Advisors
Minnesota
$309 – – –
Calamos Advisors
17
Calamos Advisors
Illinois
$166 – – –
DCM
18
Dupont Capital Management
Delaware
$166 – – –
SRF
19
Silver Rock Financial
California
$163 – – –
FFS
20
Fortress Financial Solutions
Arizona
$133 – – –
AA
21
Ancora Advisors
Ohio
$33 – – –
CF
22
Cantor Fitzgerald
New York
– -$10.5K -441,048 Closed
VF
23
Virtu Financial
New York
– +$11 +630 +3%

CEROW Hedge Fund Activity: Q3 2025 in Review

22 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q3 2025, worth a combined $38.1K — down 49% from $74.5K a quarter earlier.

Fund positioning in CEROW was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was Clear Street, adding an estimated $4.77K. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $10.5K sold.

  • 22 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q3 2025, down from 23 in Q2 2025.
  • Funds reported $38.1K of CERo Therapeutics Warrants stock for Q3 2025, down 49% quarter-over-quarter.
  • 1 fund opened new CERo Therapeutics Warrants positions in Q3 2025 and 1 closed out, a net change of 0 holders.
  • The largest CERo Therapeutics Warrants buyer in Q3 2025 was Clear Street, an estimated $4.77K added.
  • The largest CERo Therapeutics Warrants seller in Q3 2025 was Cantor Fitzgerald, an estimated $10.5K sold.

Based on aggregated 13F filings for Q3 2025.